Roxane Company Profile

What is the competitive landscape for ROXANE

ROXANE has one hundred and twenty-six approved drugs.

There are nine tentative approvals on ROXANE drugs.

Summary for Roxane

US Patents:	0
Tradenames:	74
Ingredients:	67
NDAs:	126
Patent Litigation for Roxane:	See patent lawsuits for Roxane
PTAB Cases with Roxane as petitioner:	See PTAB cases with Roxane as petitioner

Drugs and US Patents for Roxane

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Roxane	ROXICET 5/500	acetaminophen; oxycodone hydrochloride	TABLET;ORAL	089775-001	Jan 12, 1989		DISCN	No	No
Roxane	ACETAMINOPHEN AND CODEINE PHOSPHATE	acetaminophen; codeine phosphate	TABLET;ORAL	084667-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Roxane	ANAGRELIDE HYDROCHLORIDE	anagrelide hydrochloride	CAPSULE;ORAL	076489-001	Apr 18, 2005		DISCN	No	No
Roxane	CITALOPRAM HYDROBROMIDE	citalopram hydrobromide	TABLET;ORAL	077041-003	Nov 23, 2004		DISCN	No	No
Roxane	LAMOTRIGINE	lamotrigine	TABLET;ORAL	077392-001	Jan 27, 2009		DISCN	No	No
Roxane	HYDROCHLOROTHIAZIDE	hydrochlorothiazide	TABLET;ORAL	085005-001	Approved Prior to Jan 1, 1982		DISCN	No	No

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Roxane